[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/medicenna-therapeutics-corp.” connections=”true” suffix=””]

Its proprietary Empowered Cytokinesé are fusion proteins that combine the tumor selective targeting capabilities of engineered cytokines (Superkinesé) with potent pro-apoptotic (cell killing) payloads. Superkineé is a cytokine that has been engineered to bind with high affinity to a tumor specific cytokine receptor or receptor sub-type present on the surface of the target cell.